Drug-eluting versus bare-metal stents in large coronary arteries of patients with ST-segment elevation myocardial infarction: Findings from the ICAS registry

Journal of Cardiology

Volumn 64, Issue 5, 2014, Pages 377-383

  Abe, Daisuke ^a   Sato, Akira ^b   Hoshi, Tomoya ^b   Maruta, Shunsuke ^a   Misaki, Masako ^a   Kakefuda, Yuki ^c   Watabe, Hiroaki ^c   Hiraya, Daigo ^b   Sakai, Shunsuke ^b   Kawabe, Masayuki ^b   Takeyasu, Noriyuki ^a   Aonuma, Kazutaka ^b  

^a IBARAKI PREFECTURAL CENTRAL HOSPITAL   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c TSUKUBA MEDICAL CENTER HOSPITAL   (Japan)

Author keywords

Drug eluting stent; Large coronary; ST segment elevation myocardial infarction

Indexed keywords

ADULT; AGED; ARTICLE; BARE METAL STENT; BIOLIMUS ELUTING STENT; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY; DEATH; DISEASE REGISTRY; DRUG ELUTING STENT; EVEROLIMUS ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; PACLITAXEL ELUTING STENT; PERCUTANEOUS CORONARY INTERVENTION; REVASCULARIZATION; SIROLIMUS ELUTING STENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; TREATMENT OUTCOME; ZOTAROLIMUS ELUTING STENT; ADVERSE EFFECTS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COMPARATIVE STUDY; ELECTROCARDIOGRAPHY; MIDDLE AGED; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; PROCEDURES; REGISTER; RETROSPECTIVE STUDY; STENT; STROKE; THROMBOSIS; TIME;

METAL;

AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; DRUG-ELUTING STENTS; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METALS; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATIONS; REGISTRIES; RETROSPECTIVE STUDIES; STENTS; STROKE; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84912013179     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2014.02.020     Document Type: Article

References (28)

1. Keeley E.C., Boura J.A., Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003, 361:13-20.
2. Boersma E. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J 2006, 27:779-788. Primary Coronary Angioplasty vs. Thrombolysis Group.
3. Kushner F.G., Hand M., Smith S.C., King S.B., Anderson J.L., Antman E.M., Bailey S.R., Bates E.R., Blankenship J.C., Casey D.E., Green L.A., Hochman J.S., Jacobs A.K., Krumholz H.M., Morrison D.A., et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction and ACC/AHA/SCAI guidelines on percutaneous coronary intervention a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2009, 54:2205-2241.
4. Elezi S., Kastrati A., Neumann F.J., Hadamitzky M., Dirschinger J., Schömig A. Vessel size and long-term outcome after coronary stent placement. Circulation 1998, 98:1875-1880.
5. Akiyama T., Moussa I., Reimers B., Ferraro M., Kobayashi Y., Blengino S., Di Francesco L., Finci L., Di Mario C., Colombo A. Angiographic and clinical outcome following coronary stenting of small vessels: a comparison with coronary stenting of large vessels. J Am Coll Cardiol 1998, 32:1610-1618.
6. Brunner-La Rocca H.P., Kaiser C., Pfisterer M. Targeted stent use in clinical practice based on evidence from the Basel Stent Cost Effectiveness Trial (BASKET). Eur Heart J 2007, 28:719-725. BASKET Investigators.
7. Brunner-La Rocca H.P., Kaiser C., Bernheim A., Zellweger M.J., Jeger R., Buser P.T., Osswald S., Pfisterer M. Cost-effectiveness of drug-eluting stents in patients at high or low risk of major cardiac events in the Basel Stent Kosten Effektivitäts Trial (BASKET): an 18-month analysis. Lancet 2007, 370:1552-1559. BASKET Investigators.
8. Kaiser C., Galatius S., Erne P., Eberli F., Alber H., Rickli H., Pedrazzini G., Hornig B., Bertel O., Bonetti P., De Servi S., Brunner-La Rocca H.P., Ricard I., Pfisterer M. Drug-eluting versus bare-metal stents in large coronary arteries. N Engl J Med 2010, 363:2310-2319. BASKET-PROVE Study Group.
9. Moreno R., Fernández C., Alfonso F., Hernández R., Pérez-Vizcayno M.J., Escaned J., Sabaté M., Bañuelos C., Angiolillo D.J., Azcona L., Macaya C. Coronary stenting versus balloon angioplasty in small vessels: a meta-analysis from 11 randomized studies. J Am Coll Cardiol 2004, 43:1964-1972.
10. Ardissino D., Cavallini C., Bramucci E., Indolfi C., Marzocchi A., Manari A., Angeloni G., Carosio G., Bonizzoni E., Colusso S., Repetto M., Merlini P.A. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial. JAMA 2004, 292:2727-2734. SES-SMART Investigators.
11. Kastrati A., Schömig A., Dirschinger J., Mehilli J., Dotzer F., von Welser N., Neumann F.J. Randomized trial comparing stenting with balloon angioplasty in small vessels in patients with symptomatic coronary artery disease. ISAR-SMART Study Investigators. Intracoronary Stenting or Angioplasty for Restenosis Reduction in Small Arteries. Circulation 2000, 102:2593-2598.
12. Park S.W., Lee C.W., Hong M.K., Kim J.J., Cho G.Y., Nah D.Y., Park S.J. Randomized comparison of coronary stenting with optimal balloon angioplasty for the treatment of lesion in small coronary arteries. Eur Heart J 2000, 21:1785-1789.
13. Hermiller J.B., Fergus T., Pierson W., Su X., Sood P., Sudhir K., Stone G.W. Clinical and angiographic comparison of everolimus-eluting and paclitaxel-eluting stents in small coronary arteries: a post hoc analysis of the SPIRIT III randomized trial. Am Heart J 2009, 158:1005-1010.
14. Bartorelli A.L., Serruys P.W., Miquel-Hébert K., Yu S., Pierson W., Stone G.W. An everolimus-eluting stent versus a paclitaxel-eluting stent in small vessel coronary artery disease; a pooled analysis from the SPIRIT II and SPIRIT III trials. Catheter Cardiovasc Interv 2010, 76:60-66. SPIRIT II SPIRIT III Investigators.
15. Wykrzykowska J.J., Serruys P.W., Onuma Y., de Vries T., van Es G.A., Buszman P., Linke A., Ischinger T., Klauss V., Corti R., Eberli F., Wijns W., Morice M.C., di Mario C., van Geuns R.J., et al. Impact of vessel size on angiographic and clinical outcomes of revascularization with biolimus-eluting stent with biodegradable polymer and sirolimus-eluting stent with durable polymer: the LEADERS trial substudy. JACC Cardiovasc Interv 2009, 2:861-870.
16. Farb A., Boam A.B. Stent thrombosis redux - the FDA perspective. N Engl J Med 2007, 356:984-987.
17. Serruys P.W. The impact on our practice and research. EuroIntervention 2007, 2:405-407.
18. Steinberg D.H., Mishra S., Javaid A., Slottow T.L., Buch A.N., Roy P., Okabe T., Smith K.A., Torguson R., Xue Z., Pichard A.D., Satler L.F., Kent K.M., Suddath W.O., Waksman R. Comparison of effectiveness of bare-metal stents versus drug-eluting stents in large (> or =3.5mm) coronary arteries. Am J Cardiol 2007, 99:599-602.
19. Gordon P.C., Applegate R.J., Hermiller J.B., Weinsier S.B., Doostzadeh J., Cao S., Sudhir K., Lansky A.J., Stone G.W. Clinical and angiographic outcomes with an everolimus-eluting stent in large coronary arteries: the SPIRIT III 4.0mm registry. Catheter Cardiovasc Interv 2010, 75:179-186.
20. Chen Y., Wang C., Yang X., Wang L., Sun Z., Liu H., Chen L. Independent no-reflow predictors in female patients with ST-elevation acute myocardial infarction treated with primary percutaneous coronary intervention. Heart Vessels 2012, 27:243-249.
21. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000, 21:1502-1513.
22. Cutlip D.E., Windecker S., Mehran R., Boam A., Cohen D.J., van Es G.A., Steg P.G., Morel M.A., Mauri L., Vranckx P., McFadden E., Lansky A., Hamon M., Krucoff M.W., Serruys P.W. Clinical end points in coronary stent trials: a case for standard definitions. Circulation 2007, 115:2344-2351. Academic Research Consortium.
23. Pfisterer M., Brunner-La Rocca H.P., Buser P.T., Rickenbacher P., Hunziker P., Mueller C., Jeger R., Bader F., Osswald S., Kaiser C. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006, 48:2584-2591. BASKET-LATE Investigators.
24. Shugman I.M., Hee L., Mussap C.J., Diu P., Lo S., Hopkins A.P., Nguyen P., Taylor D., Rajaratnam R., Leung D., Thomas L., Juergens C.P., French J.K. Bare-metal stenting of large coronary arteries in ST-elevation myocardial infarction is associated with low rates of target vessel revascularization. Am Heart J 2013, 165:591-599.
25. Palmerini T., Biondi-Zoccai G., Della Riva D., Mariani A., Sabaté M., Valgimigli M., Frati G., Kedhi E., Smits P.C., Kaiser C., Genereux P., Galatius S., Kirtane A.J., Stone G.W. Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis. JACC 2013, 62:496-504.
26. Sabate M., Cequier A., Iñiguez A., Serra A., Hernandez-Antolin R., Mainar V., Valgimigli M., Tespili M., den Heijer P., Bethencourt A., Vazquez N., Gómez-Hospital J.A., Baz J.A., Martin-Yuste V., van Geuns R.J., et al. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial. Lancet 2012, 380:1482-1490.
27. Gomez L.J., Brugaletta S., Gomez J.A., Ferreiro J.L., Roura G., Romaguera R., Martin-Yuste V., Masotti M., Iñiguez A., Serra A., Hernandez-Antolin R., Mainar V., Valgimigli M., Tespili M., den Heijer P., et al. Everolimus-eluting stent versus bare-metal stent in proximal left anterior descending ST-elevation myocardial infarction: Insights from the EXAMINATION trial. Am Heart J 2013, 166:119-126.
28. Brodie B., Pokharel Y., Garg A., Kissling G., Hansen C., Milks S., Cooper M., McAlhany C., Stuckey T. Predictors of early, late and very late stent thrombosis after primary percutaneous coronary intervention with bare-metal and drug-eluting stents for ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 2012, 5:1043-1051.